Dr. Tan Discusses the FDA Approval of Darolutamide in M0CRPC OncLive 1:05 5 years ago 223 Далее Скачать
FDA Approves Bayer's Nubeqa (Darolutamide) for Non-Metastatic Castration-Resistant Prostate Cancer Prostate Cancer Research Institute 1:36 5 years ago 2 124 Далее Скачать
New FDA Approval: Darolutamide for Hormone-Sensitive Disease | Mark Scholz, MD | PCRI Prostate Cancer Research Institute 12:08 2 years ago 15 547 Далее Скачать
Dr. Gomella on the FDA Approval of Apalutamide for Nonmetastatic CRPC OncLive 1:10 6 years ago 272 Далее Скачать
Dr. Posadas Discusses Darolutamide in Castration-Resistant Prostate Cancer Targeted Oncology 2:40 5 years ago 338 Далее Скачать
The Addition of Darolutamide to ADT Reduces Risk of Metastasis in Nonmetastatic CRPC Targeted Oncology 0:54 5 years ago 145 Далее Скачать
FDA Approves First Treatment for Non-Metastatic, Castration-Resistant Prostate Cancer Illinois CancerCare 1:17 6 years ago 105 Далее Скачать
NUBEQA - a treatment for non-metastatic castration-resistant prostate cancer HPR 11:35 5 years ago 935 Далее Скачать
Dr. Shore on the Tolerability of Darolutamide in Nonmetastatic CRPC OncLive 2:00 4 years ago 153 Далее Скачать
Darolutamide (Nubeqa) A newly FDA-approved Drug explained in detail by Dr. Pramil Cheriyath MD ResearchMD 4:49 2 years ago 480 Далее Скачать
Dr. Fizazi on Darolutamide-Based Therapy in Nonmetastatic CRPC OncLive 1:09 5 years ago 119 Далее Скачать
Dr. Fizazi Discusses Updated Data With Darolutamide in CRPC OncLive 1:47 5 years ago 211 Далее Скачать
Examining the Impact of Darolutamide on Pain and QoL in Patients With Nonmetastatic CRPC Targeted Oncology 1:46 5 years ago 120 Далее Скачать
Dr. Lee on Choosing Among Antiandrogens in Nonmetastatic CRPC OncLive 0:55 4 years ago 80 Далее Скачать
